MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Income Overview

Revenue
$234,300K
Net Income
-$180,200K
Net Profit Margin
-76.91%
EPS
-$3.49
Unit: Thousand (K) dollars
Revenue Breakdown
    • MCMProducts Segment
    • Commercial Products Segment
    • United States Government
    • Non United States Government
Revenue Breakdown
    • Medical Countermeasures MCMProdu...
    • Commercial Product
    • All Other Revenue
Revenue Breakdown
    • United States Government
    • Non United States Government
Revenue Breakdown
    • Product And Service
    • Contracts And Grants
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Total revenues
234,300
156,100
148,700
231,100
Cost of product and services sales, net
97,100
72,000
84,900
85,900
Research and development
9,200
10,500
12,100
13,500
Selling, general and administrative
44,600
46,600
51,100
38,900
Amortization of intangible assets
17,200
16,500
16,300
16,300
Goodwill impairment
-
-
0*
-
Impairment of long-lived assets
191,300
-
12,200*
0
Total operating expenses
359,400
145,600
176,600
154,600
Income (gain) from operations
-125,100
10,500
-27,900
76,500
Interest expense
10,000
11,000
14,700
15,200
Gain on sale of business
-
-
0*
0
Loss on assets held-for-sale
-10,700
0
-
-
Loss on extinguishment of debt
-20,500
-
0*
-
Other, net
0
13,900
-8,100
-3,700
Total other income (expense), net
-41,200
2,900
-22,800
-18,900
Income (gain) before income taxes
-166,300
13,400
-50,700
57,600
Income tax provision (benefit)
13,900
6,600
3,900
6,400
Net income (gain)
-180,200
6,800
-54,600
51,200
Basic EPS
-3.49
0.13
-1.046
0.96
Diluted EPS
-3.49
0.07
-0.929
0.91
Basic Average Shares
51,600,000
51,900,000
52,200,000
53,200,000
Diluted Average Shares
51,600,000
56,500,000
58,800,000
56,500,000
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

United StatesGovernment$148,600K (157.09%↑ Y/Y)Non United StatesGovernment$19,400K (-76.65%↓ Y/Y)Non United StatesGovernment$51,400K (-38.15%↓ Y/Y)United StatesGovernment$1,000K (-98.27%↓ Y/Y)Net income (gain)-$180,200K (-1401.67%↓ Y/Y)MCMProducts Segment$168,000K (187.67%↑ Y/Y)Commercial ProductsSegment$52,400K (-22.37%↓ Y/Y)United StatesGovernment$7,500K (-87.02%↓ Y/Y)Non United StatesGovernment$6,400K (-92.30%↓ Y/Y)Income (gain) beforeincome taxes-$166,300K (-889.88%↓ Y/Y)Income tax provision(benefit)$13,900K (389.58%↑ Y/Y)Operating Segments$220,400K (75.06%↑ Y/Y)Material ReconcilingItems$13,900K (-7.33%↓ Y/Y)Income (gain) fromoperations-$125,100K (-7918.75%↓ Y/Y)Total other income(expense), net-$41,200K (-123.91%↓ Y/Y)Total revenues$234,300K (66.29%↑ Y/Y)Total operatingexpenses$359,400K (158.00%↑ Y/Y)Loss onextinguishment of debt-$20,500K Loss on assetsheld-for-sale-$10,700K Interest expense$10,000K (-31.97%↓ Y/Y)Impairment of long-livedassets$191,300K Cost of product andservices sales, net$97,100K (45.14%↑ Y/Y)Selling, general andadministrative$44,600K (2.06%↑ Y/Y)Amortization of intangibleassets$17,200K (6.17%↑ Y/Y)Research and development$9,200K (-26.40%↓ Y/Y)

Emergent BioSolutions Inc. (EBS)

Emergent BioSolutions Inc. (EBS)